NatureLab-made islet cell implants sail through diabetes trials, but are they ready yet?First-in-human studies provide hope that islet replacement therapies derived from stem cells will prove safe and effective in…
ZURICH, Jan. 12, 2026 /PRNewswire/ — NewcelX Ltd. (Nasdaq: NCEL) (“NewcelX” or the “Company”), a clinical-stage biotechnology company advancing regenerative medicine solutions, today reported the results of an international collaborative research…
A GROUNDBREAKING preclinical study has demonstrated that a chemotherapy-free, non-myeloablative conditioning regimen can induce durable mixed haematopoietic chimerism, restore immune tolerance, and completely reverse autoimmune type 1 diabetes in mouse models. The findings could pave…
Stanford researchers have cured Type 1 diabetes in mice using a combination of blood stem cell and pancreatic islet cell transplants. Researchers at Stanford Medicine have successfully prevented or cured…
A 25-year-old woman with type 1 diabetes started producing her own insulin less than three months after receiving a transplant of …
One experimentally manufactured stem Cellsamanda Smith stopped taking insulin to manage type 1 diabetes, one day before, one week before… CTV Newslondon women women for type 1 diabetes after one…
Williams R, Karuranga S, Malanda B, Saeedi P, Basit A, Besançon S, et al. Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation…
Gene-editing systems, such as CRISPR-Cas9, can be used to give stem cells immune-evasive properties.CARLOS CLARIVAN/SPL After decades of development, the dream of regenerative medicine has become a clinical reality —…